Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
about
Redox mechanisms in age-related lung fibrosisRecent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease.Analysis of Microarray-Identified Genes and MicroRNAs Associated with Idiopathic Pulmonary Fibrosis.Lung extracellular matrix and redox regulationComputational Modeling Predicts Simultaneous Targeting of Fibroblasts and Epithelial Cells Is Necessary for Treatment of Pulmonary Fibrosis.A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoidsA Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis.Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis.In Vitro Models to Study Human Lung Development, Disease and Homeostasis.An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis.Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group.Purinergic receptors: new targets for the treatment of gout and fibrosis.Role of glutathione biosynthesis in endothelial dysfunction and fibrosis.Glutaredoxin-2 controls cardiac mitochondrial dynamics and energetics in mice, and protects against human cardiac pathologies.Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function.CYP2E1 regulates the development of radiation-induced pulmonary fibrosis via ER stress- and ROS-dependent mechanisms.Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung.An Improved Method for Rapid Intubation of the Trachea in Mice.Recommendations for perioperative management of lung cancer patients with comorbidities.Effect of Pirfenidone on Vascular Proliferation, Inflammation and Fibrosis in an Abdominal Adhesion Rat Model.Treprostinil inhibits proliferation and extracellular matrix deposition by fibroblasts through cAMP activation.Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials
P2860
Q26743421-1FAE1423-7D37-4EAF-857D-D3EB51A71F1BQ33653691-EF7ACF77-9C80-4D86-BAE9-283C4A4DD7B3Q33734193-85B73A45-3725-4B47-941E-BDFD425FD3A1Q36650779-DB0C0EF9-9B50-45D3-A2C1-40597B1B785DQ37030035-1FD12A0D-0844-46B9-B174-EFBF42046B65Q37385288-2AA83062-24DB-4907-857D-569C6B441C5AQ37628170-0F21250F-C6BA-4980-AC21-EE4705D61D14Q38268556-3745CAC2-449B-4D3E-AD07-B6EA0DC71763Q38707919-63C2744A-6122-4C1C-8929-98AC84E2475CQ38811356-AB5CED99-F4FF-4B39-AA01-5595C3B4147CQ39013034-F2D3266C-31ED-4777-B23C-55241389630CQ39019348-19538250-F5D4-4AE2-9C1C-BC2FF5C5E29CQ41183598-E07E09CF-6AB4-4B2C-8136-CDCDB0C31618Q45768550-37362D9F-CECB-4E44-9E5E-711A8D859425Q45968248-00325434-7AB0-4A1C-9334-DEC9E7A960BFQ46322665-6F029604-4DF2-4123-B8D2-603FABF87C6FQ47230780-23A74383-0DBE-4FDC-83D6-1BB7544B67ABQ47578773-A8F86EAD-2AD0-479A-80C8-41367CE860AAQ47835062-C8D2B454-21D7-41E4-9AF9-95A3A4544742Q47986537-8C1794AF-0D96-477C-B5FD-10161D3419E2Q48215885-30832128-414D-4F3E-BB69-844DA8611772Q54941566-FADFF56B-C1D7-46FC-B78D-1581501CB13CQ58803268-FE473177-2B54-4E09-96EB-45858BA889E8
P2860
Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@ast
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@en
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@nl
type
label
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@ast
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@en
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@nl
prefLabel
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@ast
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@en
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@nl
P2860
P921
P3181
P356
P1476
Pharmacological treatment of i ...... ntedanib, and N-acetylcysteine
@en
P2093
Marjukka Myllärniemi
Riitta Kaarteenaho
P2860
P3181
P356
10.3402/ECRJ.V2.26385
P407
P577
2015-01-01T00:00:00Z